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A B S T R A C T
Objective: Venoplasty has been proposed, alongside the theory of chronic cerebrospinal venous
insufﬁciency (CCSVI), as a treatment for multiple sclerosis (MS). Despite concerns about its efﬁcacy and
safety, thousands of patients have undergone the procedure. This paper analyses YouTube videos where
patients have shared their treatment experiences.
Methods: Content analysis on the 100 most viewed videos from over 4000 identiﬁed in a search for
‘CCSVI’, and qualitative thematic analysis on popular ‘channels’ demonstrating patients’ experiences.
Results: Videos adopt an overwhelmingly positive stance towards CCSVI; many were uploaded by
patients and present pre- and/or post-treatment experiences. Patients demonstrate rather than merely
describe their symptoms, performing tests on themselves before and after treatment to quantify
improvement. Videos combine medical terminology and tests with personal experiences of living with
MS.
Conclusion: Social media technologies provide patients with novel opportunities for advocating for
particular treatments; generating alternative forms of ‘evidence’ built on a hybrid of personal experience
and medical knowledge.
Practice implications: Healthcare practitioners need to engage with new digital forms of content,
including online social media. Instead of disregarding sources not considered ‘evidence-based’,
practitioners should enhance their understanding of what ‘experiential-evidence’ is deemed signiﬁcant
to patients, particularly in contested areas of healthcare.
 2013 The Authors. Published by Elsevier Ireland Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
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jo ur n al h o mep ag e: w ww .e lsev ier . co m / loc ate /p ated u co u1. Introduction
The internet is frequently discussed as having the potential to
revolutionize healthcare. Yet the impact that internet technolo-
gies have on people’s health, clinical practice and policy remains
unclear. The emergence of the internet as a resource for health
information and services has had a mixed reception. It has been
hailed as a catalyst for increased patient power, more efﬁcient and
effective healthcare [1–4], while concern has been expressed
about potential harm due to incomplete or incorrect information
[5,6].
Two of the main challenges of studying and designing health-
related internet technologies are the speed of technological
change, and the diversity of tools, health conditions and contexts.§ This is an open-access article distributed under the terms of the Creative
Commons Attribution-NonCommercial-No Derivative Works License, which
permits non-commercial use, distribution, and reproduction in any medium,
provided the original author and source are credited.
* Corresponding author at: School of Applied Social Sciences, Durham University,
32 Old Elvet, Durham DH1 3HN, UK. Tel.: +44 0191 3346843.
E-mail address: fadhila.mazanderani@durham.ac.uk (F. Mazanderani).
0738-3991/$ – see front matter  2013 The Authors. Published by Elsevier Ireland Ltd
http://dx.doi.org/10.1016/j.pec.2013.06.006Broad conclusions, either negative or positive, about the con-
sequences of information technology for health are rarely accurate
[7–9]. Instead, detailed analyses of the actual use of particular
technologies in particular contexts are required. In this paper we
draw on the speciﬁc case of YouTube use by patients in relation to a
contested theory and treatment for multiple sclerosis (MS) –
chronic cerebrospinal venous insufﬁciency (CCSVI) and the
‘liberation’ procedure – to contribute to discussions on the
interaction between internet use and health.
1.1. Multiple sclerosis, CCSVI and the internet
MS, a disorder of the central nervous system, is the most
common neurological condition to affect young adults [10]. A
number of theories have been investigated to explain the cause of
MS, and it is acknowledged that it is a complex condition with
multiple aetiological factors implicated, both genetic and environ-
mental. It is widely accepted that MS is an autoimmune disease
where the body’s immune system mistakenly attacks the myelin
sheath around the nerves in the brain and spinal cord. This
demyelination results in diverse symptoms, including visual
disturbance, balance and bladder problems, stiffness and loss of. All rights reserved.
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permanent disability [10].
In 2006, Italian physician Paolo Zamboni proposed abnormalities
in cerebrospinal blood drainage as a possible aetiology for MS [11].
He termed this chronic cerebrospinal venous insufﬁciency (CCSVI)
and suggested that venous angioplasty (venoplasty) of the azygous
and jugular veins – referred to as the ‘liberation procedure’ by some
of its supporters – might improve symptoms and slow disease
progression [12]. Although vascular theories of MS are not new [13],
this proposition has been met with both excitement and concern.
Despite the novelty of the research, between 2009 and 2012
thousands of patients across the world underwent venoplasty
for CCSVI, sharing their experiences on online social media
platforms, including blogs, forums, Facebook and YouTube. This
extensive use of social media is frequently mentioned as a key
feature of CCSVI patient activism [14,15], and has been
criticized as ‘internet-based practice’ in lieu of ‘evidence-based
science’ [16]. In spite of the frequent references to CCSVI-
related internet use in academic journals and the media, there
has been no in-depth study of how people who have had the
‘liberation’ procedure actually use internet technologies and
what makes this use so compelling. In this paper we analyze
YouTube to explore: (1) how patients use video to share their
experiences and opinions of the ‘liberation’ procedure; (2)
suggest how healthcare professionals and other relevant parties
can respond to this.
1.2. Research on health-related YouTube videos
YouTube is a popular video sharing platform started in 2005.
Originally designed to host user generated content, it is now a
space where over 4 billion videos are shared on a daily basis by
organizations, advertisers, and other broadcasters. A considerable
number of health-related videos are available on YouTube, many
are produced by charitable organizations, healthcare providers,
universities, and commercial organizations; others by individuals
affected by, or with a particular interest in, a given condition.
A number of studies have been conducted on health-related
YouTube videos: immunization [17–19]; cancer [20,21]; smok-
ing [22,23]; non-suicidal self-injury [24]; partial asphyxiation
[25]; epilepsy [26]; cardiopulmonary resuscitation [27]; the
H1N1 inﬂuenza pandemic [28]; kidney stone disease [29]; organ
donation [30]; and multiple sclerosis [31]. The majority of this
research is quantitative analyses of videos, user comments and,
depending on research interest, demographic information such
as number of views, dates uploaded, country of origin, etc.
Moreover, they typically focus on assessing whether the videos
are ‘useful’ or ‘misleading’ to the public or whether a particular
medical intervention or treatment is portrayed ‘positively’ or
‘negatively’.
The conclusions drawn in this work varies and is often speciﬁc
to the context being studied, but two key themes are of particular
relevance here. The ﬁrst is the prominence of videos focused on
people’s experiences. The second is the advice given to healthcare
professionals in relation to these videos. In almost all cases the
authors suggest that healthcare practitioners need to be aware of
these videos and be prepared to respond to patients’ questions
about them; that they should engage more actively with this
content and where necessary take appropriate measures to
minimize the effect of harmful information. In contrast to our
own study, most of this literature starts with a priori assumptions
about which sources are to be trusted and what is considered
‘useful’ or ‘good’ information. Here, however, we are not interested
in assessing the medical accuracy of the CCSVI-related information
available on YouTube, but in unwrapping how different forms of
evidence are produced in patient-generated videos.2. Methods
In January 2012 the YouTube search facility was used to retrieve
all the videos identiﬁed by the search term ‘CCSVI’. Over 4000
videos were returned and the 100 most viewed selected for further
analysis. While the number of views does not indicate the number
of unique users who see the video, in the absence of more speciﬁc
metrics this is used as a rough indicator of video popularity. The
top 15 videos were analyzed by all three authors. Each author
developed their own coding scheme that categorized the videos
based on its source, content and how CCSVI was portrayed. After
discussion, a combined coding scheme was agreed on. This
categorized the videos as either a ‘patient’ or ‘non-patient’ video.
A ‘patient’ video focused on the experiences or thoughts of a
particular person with MS, while a ‘non-patient’ video was any
video that discussed CCSVI in other ways. In addition, categories
were developed to classify the content of the videos (e.g. a news
report, information and personal thoughts, fundraising) and to
assess whether CCSVI (either as a theory or the ‘liberation’
treatment speciﬁcally) was portrayed positively, negatively,
neutrally or ambiguously.
Two authors (F.M. and B.G.O.) coded the top 100 videos. The
ﬁrst 50 videos were coded separately. Based on this, the categories
were reﬁned to ensure that, as much as possible, they were
exhaustive and mutually exclusive [32]. Second, the remaining 50
videos were coded using the updated categories. Third, all the
videos were re-coded and any discrepancies resolved through
discussion. This resulted in the ‘patient’ videos being broken down
into one of nine inductively derived categories: informational and
personal thoughts; pre CCSVI videos; post CCSVI videos; pre/post
video combinations; procedures in clinic; medical images;
promotional material; advocacy/fundraising; thank you. Where
possible, gender, type of MS and medical treatment, was recorded
for each ‘patient’ video. The ‘non-patient’ videos were broken
down into ﬁve inductively derived categories: medical demon-
strations; news reports; conference presentations; promotional
material; educational material. Title, channel, number of views,
date uploaded, country of origin (if possible), was recorded for all
the videos. The results of this are presented in Table 1. Coding was
consistent across both coders with a basic percentage agreement
inter-coder reliability of 90% [33]. During the coding process 30
videos were excluded because they: (1) were not about CCSVI – 3
videos; (2) were non-English language (videos with English
subtitles were kept, as were 8 duplicate videos of a Canadian
documentary as its prominence was deemed signiﬁcant for our
analysis (discussed further below)) – 27 videos. This left 70 videos,
with views ranging from 7103 to 79,956.
Next, a qualitative thematic analysis was conducted on the 46
‘patient’ videos. Some ‘patient’ videos belonged to a ‘channel’. For
example, six of the videos analyzed belonged to a highly viewed
channel created by one patient. In cases like this, we analyzed the
entire channel in order to contextualize the videos. Constant
comparison coding that focused on what patients said as well as
how they said it was used. For each video we noted key emergent
themes, transcribed portions of the video as relevant, and read the
comments posted by viewers.
3. Results
The videos adopted an overwhelmingly positive stance towards
CCSVI (67/70: 96%); 66% (46/70) were uploaded by patients, most
of which presented pre- and/or post-treatment experiences (30/
46: 65%). Of the remaining videos, almost half were news reports
(11/24: 45%). Within our sample a Canadian documentary
produced in 2009 had been uploaded eight times and translated
into several languages (Italian, Polish, and Czech). This video
Table 1
Summary of coding results.
Total number of videos 70
Most viewed: 79,956
Least viewed: 7103
Date of newest upload: 01-October-11
Date of oldest upload: 11-September-09
Type of video Total Positive Ambiguous
‘Non-patient’ video 24 22 2
News report 11 11 0
Medical demonstration 4 4 0
Conference presentation 4 3 1
Educational material 3 2 1
Promotional material 2 2 0
Total Positive Negative Female Male Describes signs
and symptoms
Demonstrates signs
and symptoms
‘Patient’ video 46 45 1 29 17 24 19
Post procedure 14 14 0 11 3 12 6
Pre and post procedure combined 12 12 0 8 4 3 10
Pre procedure 4 3 0 3 1 3 3
Information and personal thoughts 9 9 1 4 9 5 0
Advocacy and fundraising 3 3 0 1 2 0 0
Medical images 2 2 0 1 1 0 0
Procedure being done in clinic 1 1 0 1 0 1 0
Promotional material 1 1 0 1 0 0 0
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sample it had been viewed 150,666 times across its postings. Thus,
in the context of CCSVI YouTube is not only used to share personal
experiences but, as evidenced by the popularity of this and other
videos, these experiences are located in relation to other YouTube
videos that reinforce their primarily positive message.
We found that ‘patient’ videos could be broken down into three
sub-types. The ﬁrst, ‘commercial patient experience’ videos,
focused on individual patients, but were produced by a third
party for promotional purposes. The second, ‘personal treatment
evidence’ videos, focused on the ‘liberation’ procedure and had one
or two pre/post videos directly linked to treatment. The third,
‘experiential video diaries’, belonged to a YouTube channel where
patients produced diaries about living with MS and/or CCSVI. In
what follows we focus on this qualitative analysis, but situate it in
relation to our wider analysis. These ‘patient’ videos are a rich
source of information and can be analyzed in a number of ways.
Our focus is on how ‘evidence’ is presented and discussed for or
against CCSVI and the ‘liberation’ procedure.
3.1. The power of the visual: demonstrating both signs and symptoms
Many of the most highly viewed CCSVI-related videos
presented people’s experiences pre and post the ‘liberation’
procedure. Patients not only described their symptoms and
improvements, but also demonstrated them, performing physical
tests to the camera before and after treatment. Walking and
mobility changes were quantiﬁed visually, with patients’ stepping
up and down, jumping, tying shoe laces, walking with and without
canes. Pre-treatment and post-treatment videos were frequently
ﬁlmed in the same place, with the same obstacles (e.g. stairs,
benches, foyer of house), aiding the viewer in making a direct
comparison.
In addition to physically demonstrating symptoms, patients
frequently discussed the ‘invisible’ symptoms of MS. Chronic
fatigue and cognitive dysfunction were notable examples as many
patients spoke of them as being improved post venoplasty. Many
videos referred to ‘brain fog’ – a subjective description of cognitive
dysfunction characterized by memory loss and a lack of ability to
think clearly – as a problem that was alleviated post treatment: ‘It’s
like I have a whole fog of cob webs lifted off’ (experiential videodiary; female channel 1: video A). Circulation and sensory changes,
and the amelioration of vision difﬁculties and chronic pain were
also frequently mentioned: ‘I used to have very cold feet. Freezing
feet. And they are warm’ (commercial patient experience video;
female; channel 2; video A). A wide variety of symptoms were
discussed across the videos and while changes post treatment
differed greatly, they were usually described as being signiﬁcant to
the patient. Moreover, in cases where the improvement was not
what the patient had hoped for (i.e. to be able to walk), CCSVI and
the ‘liberation’ procedure were still usually presented in a positive
light.
Whereas symptoms – ‘a disease manifestation of which the
patient complains’ [33] – were presented in videos, signs were
also incorporated (especially in personal treatment evidence
videos). There is an important distinction between the two in
clinical medicine: signs are ‘a manifestation of disease percepti-
ble to an observer’ [33] and are generally considered to be
indicative of some underlying pathology. Subjectively experi-
enced symptoms differ between people, and are elicited during
history taking in the medical encounter; signs are normally
elicited during a professional’s physical examination. Clinical
signs shown in the videos through self-examination performed
to the camera included nystagmus (involuntary eye movement),
intranuclear opthalmoplegia (problems in eye adduction often
resulting in double vision), and balancing and touching
ﬁngertips to the nose.
While the demonstration of signs was of varying success
(sometimes tests were performed incorrectly or video quality
prevented the viewer actually seeing the result), it is signiﬁcant
that elements of formal neurological examinations were per-
formed as online ‘proof’ with the video poster sometimes directly
referencing and imitating tests typically conducted in clinical
contexts, noting, for instance, ‘this is what your neurologist will get
you to do in his ofﬁce’ (personal treatment evidence video; female,
channel 3; video A). Tests such as the Rhomberg test (a component
of a neurological examination that involves standing with eyes
closed to test balance) or walking heel to toe to check for gait ataxia
were common [10]. Although less frequent, patients drew on
disability and quality of life measures to provide a more ‘objective’
measurement of their improvement (e.g. the Kurtzke Expanded
Disability Status Scale [34,35]).
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professionals
In addition to drawing on medical terminology and tests, video
posters expressed opinions on the medical profession and the
pharmaceutical industry. There was a general expression of
dissatisfaction over available MS medication; Ampyra (dalfam-
pridine), Tysabri (natalizumab), Methylprednisolone, ‘anti-seizure
medications’, Lipitor (atorvastatin), Beta-interferon, and Copaxone
(glatiramer acetate) were all mentioned. Sometimes medications
were presented as part of a pharmaceutical industry conspiracy to
make money rather than provide legitimate treatments. In a
number of videos it was suggested that neurologists and MS
Societies were anti-CCSVI because they derived an income from
current pharmacologic treatments:
The neurologists make a lot of money because they prescribe
medications, they have to be seen regularly by MS sufferers, so
if someone goes to have this CCSVI and he is better off, he feels
much better, he doesn’t need to see them, he makes no money. I
think it’s all about money. If it’s not about money they should do
it everywhere in the world (Commercial patient experience
video; male; channel 2; video B).
Interactions and relationships with speciﬁc professionals were
also discussed. Neurologists were often framed in a negative light,
although some patients spoke of cases where their neurologist had
been interested and if not supportive, then, at least, accepting of
their choices. This was in contrast with the disciplines of vascular
surgery and interventional radiology that were typically presented
more positively. Interestingly, there was minimal negativity or
suspicion regarding the potential conﬂict of interest amongst those
who provide the ‘liberation’ procedure in our sample. In one
exception to this, a man expressed concern about the ﬁnancial
incentive and lack of professionalism of a Polish clinic he had
visited. The comments posted in response to this video, were very
mixed. Some viewers expressed similar concerns about medical
tourism, while others criticized what they perceived as a negative
attitude to CCSVI.
3.3. Living with MS: the immediacy of everyday life
A third key theme that emerged from our analysis was the
personal and emotional immediacy of the videos. This was
especially the case in experiential video diaries, but was evident
in the other categories. Patients were frequently ﬁlmed in their
homes, often with family and friends in the background or behind
the camera. Family interactions were described repeatedly, from
the initial difﬁculties to the constant adaptation required as
function gradually decreased and they became more dependent on
family and loved ones. Although it is possible to video oneself,
many videos had a family member behind the camera, who
provided off camera narration noting, for instance, how much their
family members’ functioning had declined. This was juxtaposed in
several cases with their commentary after the ‘liberation’
procedure, for example: ‘Oh my god, this is amazing. . . Pretty
darn good. . . that’s crazy!’ (personal treatment evidence; male,
channel 4; video A). While family members often played a pivotal
role in recording the effects of treatment, they also gave the viewer
a personal perspective on the patient’s life, hopes and expectations,
making their experience more ‘real’.
What it is like living with MS was presented through
descriptions of daily life. One patient, created a humorous, yet
poignant, ‘day in the life of’ video to show the lived reality of MS
from her perspective. Aspirations, such as returning to work or
engaging in leisure pursuits, were discussed in relation to the
restrictions MS placed on these activities. Therefore, when actualsymptoms were described and demonstrated they were done so in
the context of a person with a life rather than as an anonymous
number in a clinical trial. Moreover, in different channels you can
view other videos the channel owner has commented on or
provided links to. While often MS related, these included other
topics of interest, such as music, pets, humorous videos, and so on.
Sometimes, video posters engaged in dialogue with each other,
explicitly mentioning other people’s videos (again, this was most
commonly the case in experiential video diaries), creating a sense
of community.
This ‘subjectivity’ did not weaken the legitimacy of the videos,
but, judging from the comments posted in response to them, for
many people it strengthened it. For instance, in response to a
positive pre/post demonstration video: ‘god bless u, i am so happy
for u. Im getting liberated in a week and you gave me hope &
strength, i was about to choke up lol, god bless u! and i am hoping
to join you real soon!’ (posted in response to personal treatment
evidence video; female; channel 5; video A). Discussion between
the video poster and viewers was common and in cases of videos
done pre or post ‘liberation’ this was often requests for information
about how the patient was doing, well wishes or exclamations
about how the video had inspired them to seek out the procedure.
While it is not possible to tell from our analysis if these videos are
actually affecting patient decision making, the high number of
views and extensive comments they receive indicate that, along
with other sources of information, they are playing a role. This
suggests that patients were making decisions based, at least in
part, on what they see on YouTube and their communication with
other patients.
4. Discussion and conclusion
4.1. Discussion
The most viewed CCSVI videos on YouTube were overwhelm-
ingly positive towards the theory and the ‘liberation’ procedure.
This contrasts with the skeptical perspective of many in the
medical community, a number of research ﬁndings and many
national MS societies [36–38]. Zamboni and other researchers
have, however, continued to publish positive ﬁndings [12] [39–41].
While the videos we analyzed were markedly positive, we are not
suggesting this be read as an assessment of treatment effectiveness
– something that remains contested. Indeed, we recognize that
there is a bias towards reporting positive results, both in research
and the media [42,43]. What we what to highlight is that many
people who feel they have had positive effects from venoplasty
have communicated this to other patients in very powerful ways
through YouTube. Scepticism of big pharma and a sense of
dissatisfaction of the available treatment for MS constituted an
important theme in our analysis. However, it is necessary to point
out that this was a very selective sample of people who had
venoplasty and had chosen to share their experiences online. Also,
many of the videos had been uploaded during 2009 and 2010,
before some of the more recent and less positive research results
had been published. This meant that many of the people posting
the videos were early adopters of the CCSVI theory. Moreover,
while there were similar themes across all three patient video
types, a strong anti-neurologist and pharma sentiment was
particularly prevalent in the commercial personal experience
videos. The experiential video diaries typically provided a more
balanced view, with patients discussing their interactions with
various professionals and responses to mainstream MS medication
and venoplasty over longer periods of time.
Unlike much existing health-related YouTube research, we have
not assessed the ‘medical’ accuracy of the videos analyzed. Instead
we are interested in how particular types of evidence are
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this: (1) the visual medium enabled vivid depictions of pre and
post treatment comparisons, often drawing on medical explana-
tions, terminology and tests adapted from clinical practice; (2)
patients not only displayed their own medical knowledge, but
discussed current MS treatments, medical professionals and big
pharma; (3) videos were situated in relation to people’s
experiences, conferring a sense of authenticity and personal
immediacy. Thus, patients drew on medical knowledge in order to
explain and reinforce their message, but, at the same time, their
status as patients conferred their thoughts, experiences and, in
some cases, advice, with a particular type of authority. The
evidence generated through these YouTube videos was, therefore,
predicated both on the language and practices of contemporary
biomedicine and personal experiences of living with MS. This was
most notably actualized in personal experience diaries, through
which trust and legitimacy can be particularly developed,
enhancing the strength of the evidence portrayed. Consequently,
it is extremely important for further research to explore the effects
of this exposure to the combination of scientiﬁc and personal
information provided by social media.
4.2. Conclusion
YouTube allows the dissemination of vivid examples of
symptom relief and functional recovery post treatment (in this
case post the ‘liberation’ procedure). It enables patients to visually
and emotively demonstrate physical performance and changes in
symptoms, turning their experiences into qualitative and quanti-
tative ‘evidence’ to ‘prove’ the effectiveness of different treat-
ments. Social media platforms such as YouTube and Facebook
enable the aggregation of individual experiences, creating a
database of experiences that patients can draw on. Moreover,
the sharing of personal experiences online can be used to advocate
for policy changes and to prioritize particular research agendas.
The increasingly mainstream adoption of social media technolo-
gies means that this type of ‘people power’ advocacy will likely
proliferate and be adopted by other groups looking to disseminate
their message [14]. In the case of CCSVI this has led to some
patients expressing extreme frustration at the slow speed of
research and policy change, while many in the medical establish-
ment have expressed an equal frustration about what they
perceive as a hijacking of the MS research agenda – seeing online
patient activism as ‘pester’ rather than people power [16].
4.3. Practice implications
The sharing of health experiences on YouTube is part of a
general rise in the sharing of experiences on social networking and
other sites that is relevant for health professionals. Rather than
simply expressing concern about the use of social media in relation
to contested and/or alternative treatments it has become impor-
tant for practitioners and researchers to engage with this content.
In many cases, interested patients will seek out information about
new and controversial treatments regardless of what they are told
in clinical consultations. Instead of dismissing information they do
not consider ‘evidence-based’, healthcare practitioners need to
enhance their understanding of the forms of evidence, especially
experiential evidence, considered signiﬁcant to patients.
Previous research has highlighted a gap between what MS
patients and clinicians rate as important to them [44]; we noted a
similar gap between CCSVI research and patient videos. Whereas
much CCSVI research focuses on ascertaining the relationship
between venous insufﬁciency and multiple sclerosis at a physio-
logical level, patients, as demonstrated in these videos, are
concerned with whether the ‘liberation’ procedure improves theirsymptoms. Videos contained discussions about aetiology, but this
was secondary to the description and demonstration of symptom-
atic improvement as a way to ‘prove’ the effectiveness of the
treatment. By gaining a better understanding of the experiences
and priorities of different patients presented in social media,
healthcare practitioners may be better able to focus on issues of
importance to patients and avoid the polarization that has taken
place in the case of CCSVI.
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